Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center (P50)
Project #
5P50AI039469-04
Application #
6201290
Study Section
Project Start
1999-07-01
Project End
2000-06-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
National School of Medicine and Pharmacy
Department
Type
DUNS #
City
Bamako
State
Country
Mali
Zip Code
Koita, Ousmane A; Murphy, Robert L; Fongoro, Saharé et al. (2016) Clinical Research and the Training of Host Country Investigators: Essential Health Priorities for Disease-Endemic Regions. Am J Trop Med Hyg 94:253-7
Krogstad, Donald J; Koita, Ousmane A; Diallo, Mouctar et al. (2015) Molecular incidence and clearance of Plasmodium falciparum infection. Malar J 14:415
Billo, Mounkaila Abdou; Diakité, Mahamadou; Dolo, Amagana et al. (2013) Inter-observer agreement according to malaria parasite density. Malar J 12:335
Koita, Ousmane A; Doumbo, Ogobara K; Ouattara, Amed et al. (2012) False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene. Am J Trop Med Hyg 86:194-8
Billo, Mounkaila A; Johnson, Eric S; Doumbia, Seydou O et al. (2012) Sickle cell trait protects against Plasmodium falciparum infection. Am J Epidemiol 176 Suppl 7:S175-85
Ouattara, Amed; Mu, Jianbing; Takala-Harrison, Shannon et al. (2010) Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine. Malar J 9:175
Djimde, Abdoulaye A; Doumbo, Ogobara K; Traore, Ousmane et al. (2003) Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg 69:558-63
Rowe, J A; Raza, A; Diallo, D A et al. (2002) Erythrocyte CR1 expression level does not correlate with a HindIII restriction fragment length polymorphism in Africans; implications for studies on malaria susceptibility. Genes Immun 3:497-500
Coulibaly, Drissa; Diallo, Dapa A; Thera, Mahamadou A et al. (2002) Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali. Am J Trop Med Hyg 67:604-10
Djimde, A; Doumbo, O K; Steketee, R W et al. (2001) Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet 358:890-1

Showing the most recent 10 out of 15 publications